Koers Peloton Therapeutics, Inc.
Aandelen
PLTX
US70614L1044
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01-11-17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01-01-11 |
David Chang
BRD | Director/Board Member | 64 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 114 mld. | |
+11,13% | 104 mld. | |
-12,76% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,18% | 17,89 mld. | |
+7,78% | 14,28 mld. | |
+35,17% | 12,55 mld. |